Stock Types

7 articles
Stock Types organizes names and concepts from stock style and capitalization name used in market and investing coverage. Items often involve asset allocation, expense ratio and diversification context, where exact wording changes how an account, filing, quote or official notice should be read.

Readers can find walk-throughs, comparisons, examples and updates tied to market risk, dividend yield and capital gains, with attention to portfolio rebalancing and stock style when those details affect costs, rights, exposure or timing.

Stock Market Valuations Reach Dubious Highs Amid Historical Precedents

U.S. stock valuations have soared to levels seen only a handful of times since 1871, raising concerns about short-term downside risk even as long-term investors weigh the lessons of past market cycles

View Story

Rivian Gets Price Target Boost as Robotaxi Ambitions Draw Focus

Rivian stock has lagged in 2026, but a major Wall Street upgrade and new delivery targets are shifting investor attention to the company's robotaxi strategy and mass-market EV rollout

View Story

Walmart's Stock Splits: What 12 Splits Mean for Investors

Walmart has split its stock 12 times since 1971, most recently in 2024. Here's how these splits affect shareholders, why the company keeps shares accessible, and what could trigger another split in the future

View Story

Cathie Wood Doubles Down on SpaceX as Stock Slides Below IPO Price

SpaceX shares have dropped more than 11% below their IPO price, but ARK Invest just made a $20.5 million bet on the company. Investors are weighing Starship delays, valuation risks, and a looming lockup expiration

View Story

Warren Buffett's Cash Strategy Signals Caution in a Risk-Heavy Market

As speculative trading surges and traditional value investing gets sidelined, Warren Buffett is holding a record $397 billion in cash-raising questions about whether patience is the smartest move for investors facing today's market frenzy

View Story

Ionis Pharmaceuticals Stock Plunges After Consecutive Drug Setbacks

Ionis Pharmaceuticals shares tumbled nearly 29% in two days after a failed heart drug trial and a partner’s exit from Huntington’s disease programs, raising questions about future growth and competition in the biotech sector

View Story

SpaceX IPO Turns Thousands of Workers Into Millionaires - For Now

SpaceX’s record-breaking IPO minted over 4,400 employee millionaires, from welders to executives, but falling share prices and strict lockup rules mean most can’t cash out yet and face real risks to their newfound wealth

View Story